Evelo Biosciences Aktie Analyse
29.01.19 | Evelo Biosciences Neutral | Chardan Capital Markets | |
08.06.18 | Evelo Biosciences Outperform | BMO Capital Markets |
Werbung
29.01.19 | Evelo Biosciences Neutral | Chardan Capital Markets | |
08.06.18 | Evelo Biosciences Outperform | BMO Capital Markets |